Zealand Pharma — Director's Dealing 2018

Mar 8, 2018

FINANSTILSYNET

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Mats Blom
2.	Reason for the notification
a)	Position/status	Executive Vice President and Chief Financial Officer in Zealand Pharma A/S
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI¹	549300ITBB1ULBL4CZ12
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument
Identification code	Shares
DK0060257814
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 93,12	11,750
		DKK 93,16	1,250
d)	Aggregated information
- Aggregated volume
- Price	DKK 1,210,610
e)	Date of the transaction	8 March 2018
f)	Place of the transaction	Nasdaq Copenhagen A/S, XCSE